Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?

Authors

  • Anna S. Lok M.D.

    Corresponding author
    1. Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI
    • University of Michigan Health System, 3912 Taubman Center, SPC 5362, 1500 East Medical Center Drive, Ann Arbor, MI 48109
    Search for more papers by this author
    • fax: 734-936-7024


  • See Article on Page 1185.

  • Potential conflict of interest: Dr. Lok is a consultant for and received grants from Bristol-Myers Squibb, Gilead, and Roche. She also received grants from Glaxo-SmithKline, Novartis, and Schering-Plough.

No abstract is available for this article.

Ancillary